We thus expressed four different subset no. 4 CLL-derived BcRs in a RAG2/λ5/SLP65 triple knockout murine pre-B-cell line (TKO cells)26 engineered to include a tamoxifen-inducible ERT2-SLP65 fusion protein22. This evidence concerns the gene MAPK3 and B-cell chronic lymphocytic leukemia.